Related Experiment Videos
Competitive enzyme-linked immunoassay for Factor VIII antigen.
Clinical Chemistry
|November 1, 1979
Summary
A new competitive enzyme-linked immunoassay was developed for measuring Factor VIII antigen. This rapid and sensitive assay provides results comparable to existing methods, aiding in the diagnosis and management of bleeding disorders.
Area of Science:
- Clinical Chemistry
- Immunology
- Hematology
Background:
- Factor VIII antigen levels are critical indicators in diagnosing and managing bleeding disorders like hemophilia A.
- Accurate and efficient quantification of Factor VIII antigen is essential for effective patient care.
Purpose of the Study:
- To develop and validate a novel competitive enzyme-linked immunoassay (ELISA) for quantifying Factor VIII antigen.
- To establish a rapid, sensitive, and reproducible method for Factor VIII antigen measurement.
Main Methods:
- A competitive ELISA was designed utilizing solid-phase Factor VIII antigen and a heterologous bridging antibody.
- A soluble antibody/enzyme immune complex (rabbit antiperoxidase/horseradish peroxidase) was employed for detection.
- Peroxidase activity was measured spectrophotometrically, inversely correlating with Factor VIII antigen concentration.
Main Results:
- The assay demonstrated sensitivity down to 0.05 units of Factor VIII antigen per milliliter.
- Reproducibility, linearity, and normal range were found to be comparable to established techniques.
- The entire assay procedure could be completed within 4 hours.
Conclusions:
- The developed competitive ELISA offers a fast and reliable method for Factor VIII antigen quantification.
- This assay is suitable for clinical laboratory use, providing accurate results with high sensitivity.
- The assay's efficiency and comparable performance make it a valuable tool in hematology diagnostics.